Loading...

Abliva AB (publ)

NEVPFPNK
Healthcare
Biotechnology
$0.03
$0.00(0.00%)

Abliva AB (publ) (NEVPF) Stock Overview

Explore Abliva AB (publ)’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap45.1M
P/E Ratio-3.78
EPS (TTM)$-0.01
ROE-1.33%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.01

NEVPF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Abliva AB (publ) (NEVPF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.78 and a market capitalization of 45.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;